ED presentations for mRNA COVID‐19 vaccination‐related chest complaints, as measured by the conduct of troponin tests in children <18 years of age, increased 30‐fold compared to prior to roll out of the vaccine. Of 283 vaccine‐related chest complaints, only 14 (5%) were found to have Brighton criteria‐defined myocarditis and none had pericarditis. Myocarditis outcomes were benign. Although mRNA COVID‐19 vaccinations (Comirnaty BNT162b2 COVID‐19 [Pfizer‐BioNTech] and Spikevax mRNA‐1273 [Moderna]) led to increased emergency presentations, the incidence of confirmed inflammatory heart conditions was low.
All Keywords
【저자키워드】 COVID‐19, myocarditis, Pericarditis, paediatric, Vaccinations,
【저자키워드】 COVID‐19, myocarditis, Pericarditis, paediatric, Vaccinations,